Passion towards science and research
DR SARAL THANGAM CEO & Managing Director, Norwich Clinical Services, India
North American company Norwich has been serving the pharmaceutical industry for more than 100 years. In 2010, Norwich Pharmaceuticals, an Alvogen subsidiary, announced the formation of Norwich Clinical Services to provide clinical Research capabilities for further expanding the company’s third party services.
Dr Saral Thangam then took the lead in setting up the CRO in Bengaluru, with an experienced team of professionals, each having more than 15 years of experience in clinical research and life sciences. Today, Norwich Clinical Services has state– of-the-art facilities, and exceptional expertise to conduct bioavailability and bioequivalence studies, clinical trials, drug metabolism studies, dose proportionality studies, multiple dose studies and pharmacovigilance.
Prior to joining Norwich, Dr Saral Thangam was the managing director of Lotus Labs. In addition, she has headed various operational units, including clinical pharmacology, clinical development, quality assurance and business development at Lotus. She has published and presented many research papers in scientific forums in international conferences.
The company started with around 20 employees, and under the expert guidance of Saral Thangam, the number has now reached close to
200. “We understand the complexities of drug development whether biotech, generic or pharma. Each member of our team has extensive experience in their area of expertise including leadership positions in the pharmaceutical sector and contract research organizations,” shared Dr Saral Thangam.
Dr Saral Thangam is a medical graduate from Christian Medical College, Vellore, and has a post graduate specialization in the field of Internal Medicine. She also holds a PhD in Physiology from St. John’s National Academy of Health Sciences in India. This passion towards science and research led her to the position she currently holds in her career of more than 20 years.
Norwich Clinical Services is focused on quality, with multiple successful audits by USFDA, EMA and WHO. Their facilities are certified by Indian DCGI, the Brazilian Agency ANVISA and MOH Turkey. With an annual revenue around Rs 60 crore, Norwich Clinical Services has gained tremendous growth in the field of pharmacovigilance over the years. “Many CROs were facing problems few years back due to regulatory issues. Studies were being withdrawn from India during this phase of uncertainty. But we held on and focused our attention on pharmacovigilance and drug safety, and expanded in this direction”.
She is a winner of several awards including prestigious Shakuntala Amirchand Award for significant contribution to biomedical sciences by the Indian Council of Medical Research (ICMR). Currently, she is part of the Executive Council at the Association of Clinical Research Organisation (ACRO).
“Norwich also offers corporate training services in various areas of clinical research for the Pharmaceutical, Clinical Research, Biotechnology and IT sectors. In the coming years, we are planning to work more in the direction of biosimilars”, said Dr Saral Thangam.
DR SARAL THANGAM
CEO & Managing Director, Norwich Clinical Services, India